Cutler Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Cutler Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,000	Closed	-$19K	–	7061
2015 Q4	$19K	Buy	+7,000	New	+$76.7K	﹤0.01%	3471

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cutler Group's RDY Position: Q1 2018 in Review

Cutler Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 5 shares.

Cutler Group first reported a position in RDY in Q4 2015 and held it in 8 quarters. The position peaked at $318K in Q4 2015. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

Cutler Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
Cutler Group sold 5 Dr. Reddy's Laboratories shares in Q1 2018.
Cutler Group first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 8 quarters.
Cutler Group's Dr. Reddy's Laboratories position peaked at $318K in Q4 2015.
121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.